Absci (ABSI) Revenue (2020 - 2026)

Absci's (ABSI) quarterly Revenue came in at $215000.0 in Q1 2026, down 81.76% year-on-year from $1.2 million in Q1 2025, and down 66.92% quarter-over-quarter from $650000.0 in Q4 2025.

Absci (ABSI) Revenue (2020 - 2026) Analysis & Trends

Absci has disclosed Revenue across 7 years of filings, most recently posting $215000.0 for Q1 2026.

  • Revenue for Q1 2026 came in at $215000.0, down 81.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 61.87% YoY), and the FY2025 annual result was $2.8 million, down 38.24% from the prior year.
  • Revenue came in at $215000.0 for Q1 2026 at Absci, down from $650000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.4 million in Q2 2023 to a low of $122000.0 in Q4 2022.
  • The 5-year median for Revenue is $744000.0 (2023), against an average of $1.0 million.
  • Peak annual rise in Revenue reached 636.76% in 2022, while the deepest fall reached 82.03% in 2022.
  • Absci's Revenue stood at $122000.0 in 2022, then soared by 177.05% to $338000.0 in 2023, then jumped by 96.75% to $665000.0 in 2024, then fell by 2.26% to $650000.0 in 2025, then sank by 66.92% to $215000.0 in 2026.
  • The last three Revenue figures came in at $215000.0 (Q1 2026), $650000.0 (Q4 2025), and $378000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 215,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 215,000.00
Dec 31, 2025 650,000.00
Sep 30, 2025 378,000.00
Jun 30, 2025 593,000.00
Mar 31, 2025 1.18 Mn
Dec 31, 2024 665,000.00
Sep 30, 2024 1.70 Mn
Jun 30, 2024 1.27 Mn
Mar 31, 2024 898,000.00
Dec 31, 2023 338,000.00
Sep 30, 2023 744,000.00
Jun 30, 2023 3.37 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 122,000.00
Sep 30, 2022 2.37 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 365,000.00
Dec 31, 2021 679,000.00
Sep 30, 2021 1.39 Mn
Jun 30, 2021 136,000.00